1. Home
  2. HSDT vs AQMS Comparison

HSDT vs AQMS Comparison

Compare HSDT & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • AQMS
  • Stock Information
  • Founded
  • HSDT N/A
  • AQMS 2014
  • Country
  • HSDT United States
  • AQMS United States
  • Employees
  • HSDT 21
  • AQMS N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AQMS Metal Fabrications
  • Sector
  • HSDT Health Care
  • AQMS Industrials
  • Exchange
  • HSDT Nasdaq
  • AQMS Nasdaq
  • Market Cap
  • HSDT 6.4M
  • AQMS 5.1M
  • IPO Year
  • HSDT N/A
  • AQMS 2015
  • Fundamental
  • Price
  • HSDT $6.00
  • AQMS $4.20
  • Analyst Decision
  • HSDT Hold
  • AQMS Buy
  • Analyst Count
  • HSDT 1
  • AQMS 1
  • Target Price
  • HSDT N/A
  • AQMS $30.00
  • AVG Volume (30 Days)
  • HSDT 27.8K
  • AQMS 35.1K
  • Earning Date
  • HSDT 08-14-2025
  • AQMS 08-13-2025
  • Dividend Yield
  • HSDT N/A
  • AQMS N/A
  • EPS Growth
  • HSDT N/A
  • AQMS N/A
  • EPS
  • HSDT N/A
  • AQMS N/A
  • Revenue
  • HSDT $295,000.00
  • AQMS N/A
  • Revenue This Year
  • HSDT N/A
  • AQMS N/A
  • Revenue Next Year
  • HSDT $75.13
  • AQMS $550.00
  • P/E Ratio
  • HSDT N/A
  • AQMS N/A
  • Revenue Growth
  • HSDT N/A
  • AQMS N/A
  • 52 Week Low
  • HSDT $5.37
  • AQMS $3.37
  • 52 Week High
  • HSDT $1,200.00
  • AQMS $46.00
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 28.43
  • AQMS 51.48
  • Support Level
  • HSDT $5.81
  • AQMS $3.55
  • Resistance Level
  • HSDT $6.57
  • AQMS $3.96
  • Average True Range (ATR)
  • HSDT 0.34
  • AQMS 0.29
  • MACD
  • HSDT 0.84
  • AQMS 0.12
  • Stochastic Oscillator
  • HSDT 24.18
  • AQMS 84.18

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: